Find Funding Opportunities

The purpose of this notice is to notify applicants of a correction to the Award Project Period for PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)".

The purpose of this notice is to inform applicants of a correction to the Eligible Applicants for RFA-NS-24-024 "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)". This NOFO has been revised to show that Non-domestic (non-U.S.) Entities (Foreign Institutions) are NOT eligible to apply.

TheNINDSOffice of Global Health and Health Disparities (OGHHD)will host a pre-application technical assistance webinar for those considering applying to the Community-Engaged Health Equity Research in Neuroscience (HERN) Initiative Funding Opportunities. NIH staff will discuss the funding opportunities and answer questions from prospective applicants. Participation in the webinar is encouraged but optional.

The purpose of this notice is to notify applicants of a correction to the table of page limits and Instructions for Submission of Multicomponent Applications for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)".

This Notice of Funding Opportunity (NOFO) solicits applications for one or more Data Coordinating Centers (DCCs) to support BRAIN CONNECTS, a networked consortium of Comprehensive Centers and Specialized Projects funded under RFA-NS-22-047, RFA-NS-22-048, and RFA-NS-22-049. The goals of these awards are to develop the research capacity and technical capabilities for comprehensive brain-wide connectivity mapping in mouse, human, and non-human primate (NHP). BRAIN CONNECTS projects will collect and process unprecedented volumes of anatomical data by scaling up cutting-edge acquisition modalities and analysis methods, to demonstrate the feasibility of collecting, reconstructing, analyzing, integrating, disseminating, and interpreting connectivity maps from entire brains. The resulting feasibility data from these awards are expected to inform NIH decisions on program continuation in a potential subsequent five-year funding period for production of brain-wide wiring diagrams. NIH expects to fund one or more BRAIN CONNECTS DCCs, which will collaborate with CONNECTS data generating projects to (1) coordinate activities of the BRAIN CONNECTS Network, (2) develop and harmonize common data processing pipelines, (3) integrate and disseminate data analytic tools and capabilities, (4) establish a unified knowledge base for connectivity data of diverse modalities, and (5) organize and implement outreach and engagement to the wider research community and the general public. Awards will be integrated into the BRAIN CONNECTS Network as a coordinated effort aimed at developing the ability to generate wiring diagrams spanning entire brains across multiple scales and species.

The purpose of this Notice is to announce the collaboration between the NIH and the National Science Foundation (NSF) on an interagency funding opportunity, NSF-23-614, Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science.

The purpose of this notice is to inform potential applicants about allowing them to charge Participant Support Costs in the Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) Notice of Funding Opportunity (NOFO), PAR-21-314.

The purpose of this notice is to correct the instructions to applicants for reasonable accommodations in PAR-22-181 "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".

The purpose of this notice is to inform applicants of a change to the Award Budget for RFA-NS-21-029 "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed). The Award Budget changes to the Notice of Funding Opportunity (NOFO) are shown below.

The purpose of this notice is to inform applicants of the early termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". The September 7, 2023 AIDS date has been cancelled.